Krystal Biotech Inc.

181.44
6.86 (3.93%)
At close: Apr 02, 2025, 3:59 PM
181.00
-0.24%
After-hours: Apr 02, 2025, 04:05 PM EDT

Krystal Biotech Cash Flow Statement

Year FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16
Net Income 89.16M 10.93M -139.97M -69.57M -32.17M -19.09M -10.89M -7.92M -1.15M
Depreciation & Amortization 6.71M 5.01M 4.05M 2.77M 1.85M 748K 141K 23K 2K
Stock-Based Compensation 49.13M 39.93M 33.23M 15.32M 3.27M 1.24M 792K 246K 33K
Other Working Capital 59.15M 8.73M 4.07M 1.34M 145K -1.48M 399K 365K -245K
Other Non-Cash Items -7.12M -106.79M -690K 1.49M 33K 67K 962K 3.26M 7K
Deferred Income Tax n/a n/a n/a n/a n/a n/a n/a n/a n/a
Change in Working Capital -14.46M -37.88M 2.81M 2.05M 928K -1.68M 511K 498K -203K
Operating Cash Flow 123.42M -88.8M -100.57M -47.94M -26.08M -18.71M -9.45M -3.89M -1.31M
Capital Expenditures -4.24M -11.8M -52.98M -68.34M -14.84M -6.4M -2.23M -210K -15K
Acquisitions n/a n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments -457.74M -508.78M -318.78M -190.46M -3.21M -9.07M -8.09M n/a n/a
Sales Maturities Of Investments 298.54M 503.21M 257.68M 32.03M 6.87M 10.5M n/a n/a n/a
Other Investing Acitivies n/a 100M n/a n/a n/a n/a n/a n/a n/a
Investing Cash Flow -163.44M 82.64M -114.08M -226.77M -11.18M -4.97M -10.32M -210K -15K
Debt Repayment n/a n/a n/a n/a n/a n/a n/a 2.3M 1.84M
Common Stock Repurchased n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies 27.01M -749K -649K -7.96M n/a n/a n/a n/a n/a
Financial Cash Flow 27.01M 202.75M 35.35M 347.69M 118.02M 107.53M 73.85M 51.77M 3.25M
Net Cash Flow -13.46M 196.43M -179.35M 72.98M 80.75M 83.84M 54.08M 47.67M 1.92M
Free Cash Flow 119.18M -100.6M -153.55M -116.27M -40.93M -25.11M -11.68M -4.1M -1.33M